DexCom (DXCM) - P/S ratio

P/S ratio as of March 2026 (TTM): 5.21

According to DexCom's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.84. At the end of 2025 the company had a P/S ratio of 5.60.

P/S ratio history for DexCom from 2007 to 2025

PS ratio at the end of each year

Year	P/S ratio	Change
2025	5.60	-27.98%
2024	7.77	133.38%
2023	3.33	-78.2%
2022	15.3	-28.13%
2021	21.3	15.35%
2020	18.4	35.74%
2019	13.6	29.88%
2018	10.5	50.57%
2017	6.94	-21.14%
2016	8.80	-47.12%
2015	16.6	1.39%
2014	16.4	2.32%
2013	16.0	69.65%
2012	9.46	14.76%
2011	8.24	-52.7%
2010	17.4	39.24%
2009	12.5	49.55%
2008	8.37	-84.68%
2007	54.6

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Johnson & Johnson JNJ	6.15	18.13%	🇺🇸 USA
Abbott Laboratories ABT	4.08	-21.72%	🇺🇸 USA
Medtronic MDT	3.15	-39.46%	🇮🇪 Ireland
Becton Dickinson BDX	2.55	-50.97%	🇺🇸 USA
Edwards Lifesciences EW	7.59	45.83%	🇺🇸 USA
Tandem Diabetes Care TNDM	1.42	-72.64%	🇺🇸 USA
QuidelOrtho QDEL	0.3707	-92.88%	🇺🇸 USA
West Pharmaceutical Services WST	5.71	9.57%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for DexCom (DXCM)

P/S ratio as of March 2026 (TTM): 5.21